Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

$7bn Indian insurance IPO fails to cover book

Indian private health insurer Star Health has seen just short of four-fifths of its IPO offer subscribed in the past three days of book building. However, local press reports that the listing will still go through thanks to a downsized secondary offer.

Russian oxygen supplies dwindle

Parts of Russia are facing significant oxygen shortages as the treatment of Covid patients continues to chip away at reserves.

IHH considers divesting in China

Listed Malaysian hospital group IHH Healthcare is considering a divestment of its loss-making Chinese business, it has told the stock exchange. Parkway Group could sell for US$1bn.

Booster blunder puts staff at risk

The Indian government's slowness to approve booster shots is putting lives at risk - particularly those of front line medical staff whose immunity is waning. HBI speaks to a disappointed operator source in the country to find out more.

Rising costs force EBITDA crash for hospitals

EBITDA has crashed among most of Europe's biggest hospital groups despite high single-digit revenue growth. Last-minute cancellations, supply chain issues and rising energy prices are all among the culprits.

Aster DM to focus on ‘high-growth’ Indian business

UAE and Indian hospital business Aster DM has tasked bankers to look at a demerger between the two geographies. Chairman Azad Moopen has said this makes more room for capex on the high-growth Indian business. 

South African hospitals recover despite no state support

The South African government made almost no use of private sector capacity during the pandemic, HBI hears, sending less than 100 COVID patients to be treated in the private sector. However, results point to a bounceback for the ‘Big Three’. 

Fresenius Helios expands in Colombia

Quironsalud, the Spanish arm of Fresenus Helios has expanded its Colombian business with the acquisition of Centro Oncológico de Antioquia and ophthalmology centre Clínica Clofán. In its nine month results Fresenius stated that Latin America were strong and "notably above expectations." We look at a booming market where Fresenius Helios spent the lion's share of its €770m on M&A deals in 2020 and 2019 alone.

Russia kickstarts remote diagnoses

Russia has just started a new three-year pilot that allows specific providers to make remote diagnoses and prescriptions, it is one of the last countries in Europe to deregulate telehealth. 

Find Us